GILD vs PED · P/E 18, rev $29.44B vs P/E 3.3, rev $39.6M
Gilead Sciences Inc (GILD) versus PEDEVCO Corp (PED) — a side-by-side from cached financials, not a winner call.
Gilead Sciences Inc (GILD) is a drug manufacturers - general company listed on US.
PEDEVCO Corp (PED) is a oil & gas e&p company listed on US.
Latest reported GILD revenue for 2025-12-31 was $29.44B. Net income was $8.51B. Revenue was up 2.4% from 2024-12-31 to 2025-12-31. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
Latest reported PED revenue for 2024-12-31 was $39.6M. Net income was $17.8M. Revenue was up 28.5% from 2023-12-31 to 2024-12-31. PED currently screens at market cap $57.1M and trailing P/E 3.3.
GILD currently screens at market cap $160.15B and trailing P/E 17.5. PED currently screens at market cap $57.1M and trailing P/E 3.3.
Not investment advice. Open the GILD and PED stock pages for the full models.
Not investment advice.